... really torques me off:
May 10, 2012
Today the U.S. Food and Drug Administration released a safety communication to inform people with MS, doctors and others about potential risks associated with procedures and devices used to treat CCSVI (chronic cerebrospinal venous insufficiency). The communication from the FDA outlines these risks and encourages more research to provide better understanding of the relationship between CCSVI and MS and to guide possible treatment decisions by people with MS and their health care providers.
Yeah, right. The MS Society has only recently gotten onboard with CCSVI research because there was such a groundswell of support for more research by actual sufferers.
Look ... it's sad but true ... no company wants to cure anything, because if they cured anything, there would be no need for them to treat anything.
pm
No comments:
Post a Comment